A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort

Neuro Oncol. 2020 May 15;22(5):729-731. doi: 10.1093/neuonc/noaa027.

Authors

Ming-Zhi Han¹, Bin Huang¹, Shi-Lei Ni¹, Jian Wang¹, Xin-Gang Li¹, Rolf Bjerkvig¹

Affiliation

¹ NorLux Neuro-Oncology Laboratory, University of Bergen, Bergen, Norway (M-Z.H., J.W., R.B.); Department of Neurosurgery, Qilu Hospital of Shandong University and Institute of Brain and Brain-Inspired Science, Shandong University, and Shandong Key Laboratory of Brain Function Remodeling, Jinan, China (M-Z.H., B.H., S-L.N., J.W., X-G.L.); NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (R.B.).

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Asian People
Cohort Studies
Glioma*
Humans
Nomograms*
Prognosis